AU776955B2 - Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin - Google Patents
Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin Download PDFInfo
- Publication number
- AU776955B2 AU776955B2 AU31454/00A AU3145400A AU776955B2 AU 776955 B2 AU776955 B2 AU 776955B2 AU 31454/00 A AU31454/00 A AU 31454/00A AU 3145400 A AU3145400 A AU 3145400A AU 776955 B2 AU776955 B2 AU 776955B2
- Authority
- AU
- Australia
- Prior art keywords
- tissue
- viruses
- virus
- hmgi
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19904514A DE19904514A1 (de) | 1999-02-04 | 1999-02-04 | Mittel zur Prävention und/oder Behandlung von Leiomyomen |
| DE19904514 | 1999-02-04 | ||
| DE19943787A DE19943787A1 (de) | 1999-09-13 | 1999-09-13 | Mittel zur Prävention und/oder Behandlung von Gewebeveränderungen mesenchymalen Ursprungs |
| DE19943786 | 1999-09-13 | ||
| DE19943786A DE19943786A1 (de) | 1999-09-13 | 1999-09-13 | Mittel zur Prävention und/oder Behandlung von Gewebeveränderungen mesenchymalen Ursprungs |
| DE19943787 | 1999-09-13 | ||
| PCT/DE2000/000364 WO2000045851A2 (de) | 1999-02-04 | 2000-02-04 | Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3145400A AU3145400A (en) | 2000-08-25 |
| AU776955B2 true AU776955B2 (en) | 2004-09-30 |
Family
ID=27218954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU31454/00A Ceased AU776955B2 (en) | 1999-02-04 | 2000-02-04 | Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20070202115A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1146881B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002536345A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE314854T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU776955B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2360942A1 (cg-RX-API-DMAC10.html) |
| DE (2) | DE50012015D1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2000045851A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8722411B2 (en) | 2009-10-07 | 2014-05-13 | The State Of Israel, Ministry Of Agriculture & Rural Development, Kimron Veterinary Institute | Brucella phage polynucleotides and uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998021201A1 (en) * | 1996-11-14 | 1998-05-22 | Takeda Chemical Industries, Ltd. | Crystals of benzimidazole derivatives and their production |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996016629A2 (en) * | 1994-11-18 | 1996-06-06 | Amira Inc | Phosphinic creatine compounds having antiviral activity |
| US5972666A (en) * | 1996-07-26 | 1999-10-26 | G. D. Searle & Co. | Assembly-deficient herpesvirus vaccine |
| GB9623522D0 (en) * | 1996-11-11 | 1997-01-08 | Pharmacia & Upjohn Spa | Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents |
-
2000
- 2000-02-04 AU AU31454/00A patent/AU776955B2/en not_active Ceased
- 2000-02-04 WO PCT/DE2000/000364 patent/WO2000045851A2/de not_active Ceased
- 2000-02-04 JP JP2000596970A patent/JP2002536345A/ja active Pending
- 2000-02-04 DE DE50012015T patent/DE50012015D1/de not_active Expired - Lifetime
- 2000-02-04 DE DE10080190T patent/DE10080190D2/de not_active Expired - Fee Related
- 2000-02-04 CA CA002360942A patent/CA2360942A1/en not_active Abandoned
- 2000-02-04 AT AT00909001T patent/ATE314854T1/de not_active IP Right Cessation
- 2000-02-04 EP EP00909001A patent/EP1146881B1/de not_active Expired - Lifetime
-
2006
- 2006-11-17 US US11/601,255 patent/US20070202115A1/en not_active Abandoned
-
2009
- 2009-03-14 US US12/404,292 patent/US20090304708A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998021201A1 (en) * | 1996-11-14 | 1998-05-22 | Takeda Chemical Industries, Ltd. | Crystals of benzimidazole derivatives and their production |
Non-Patent Citations (2)
| Title |
|---|
| CORDERO F ET AL, AIDS 11(14) P 1787-8 * |
| REYEZI JA ET AL, ORAL SURG. OR MED. OR PATHOL. 81(1) 55-62 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070202115A1 (en) | 2007-08-30 |
| JP2002536345A (ja) | 2002-10-29 |
| EP1146881A2 (de) | 2001-10-24 |
| EP1146881B1 (de) | 2006-01-04 |
| US20090304708A1 (en) | 2009-12-10 |
| AU3145400A (en) | 2000-08-25 |
| ATE314854T1 (de) | 2006-02-15 |
| WO2000045851A3 (de) | 2000-12-28 |
| DE10080190D2 (de) | 2002-01-24 |
| CA2360942A1 (en) | 2000-08-10 |
| WO2000045851A2 (de) | 2000-08-10 |
| DE50012015D1 (de) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101448848B (zh) | Ras突变及其相关组合物和方法 | |
| DK2081586T3 (en) | RSPONDINES AS MODULATORS OF ANGIOGENESE AND VASCULOGENESES | |
| KR100355111B1 (ko) | 발췌제거cDNA라이브러리제조법및제조된라이브러리의용도 | |
| KR20040072626A (ko) | 혈액학적 악성종양의 검출, 진단 및 치료용 조성물 및 방법 | |
| JP2007502612A (ja) | コロナウイルス、核酸、蛋白質、ならびにワクチンの生成方法、薬剤および診断 | |
| MX2010008168A (es) | Biomarcadores p53. | |
| JP2009100768A (ja) | 腫瘍形成形質転換に関連する内因性レトロウイルスポリペプチド | |
| US6322794B1 (en) | Seroreactive epitopes on proteins of human papillomavirus (HPV) 18 | |
| KR100204258B1 (ko) | 재조합 고양이 코로나바이러스 에스 단백질 | |
| CN1643148B (zh) | 小鼠精子形成基因、人男性不育关连基因、以及利用该基因的诊断系统 | |
| KR20140134923A (ko) | Tgfbi를 이용한 패혈증 진단용 조성물 및 이를 이용한 패혈증 예방 또는 치료용 약학적 조성물과 이의 스크리닝 방법 | |
| WO2010011952A2 (en) | Highly potent peptides to control cancer and neurodegenerative diseases | |
| JPH09510346A (ja) | 哺乳動物細胞における新生物形質転換の制御に関連する遺伝子および遺伝学的因子 | |
| AU2002233299B2 (en) | Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes | |
| US20130316958A1 (en) | Highly potent peptides to control cancer and neurodegenerative diseases | |
| JPH11514864A (ja) | ヘルペスウイルスのrfhv/kshv亜科の糖タンパク質b | |
| CN113384700A (zh) | 一种能有效抑制埃博拉病毒感染的靶点ly6e及其应用 | |
| Atreya et al. | The rubella virus putative replicase interacts with the retinoblastoma tumor suppressor protein | |
| EA009782B1 (ru) | Пептид, происходящий из вируса гепатита с | |
| US20090304708A1 (en) | Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin | |
| WO2000014263A9 (en) | Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them | |
| US6569616B1 (en) | Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate | |
| JP7764502B2 (ja) | 環状RNA Circ-ACE2翻訳によるポリペプチド及びその使用 | |
| Wang et al. | GB virus type C E2 protein inhibits human immunodeficiency virus type 1 gag assembly by downregulating human ADP-ribosylation factor 1 | |
| CN111808938A (zh) | Atp6v0d2用于动脉粥样硬化的早期诊断或疗效监控 |